When a supplier lists epithalon purity at over 99%, that number should mean something specific. For researchers sourcing the tetrapeptide Ala-Glu-Asp-Gly, epithalon purity is only as useful as the methodology behind it — and methodology varies considerably across the market.
This is a breakdown of how epithalon purity is measured, what a credible certificate of analysis should show, and where the meaningful differences between vendors actually appear.
What “Over 99% Purity” Means for a Tetrapeptide
Purity in peptide chemistry typically refers to the percentage of the target compound present in the final lyophilized product, measured by area under the curve in a reversed-phase HPLC run. For epithalon — a four-amino-acid chain — the main impurities are synthesis byproducts: truncated sequences from missed couplings, deletion peptides, and oxidized variants of the aspartic acid or glutamic acid residues.
A >99% figure means that roughly 99 out of every 100 parts of the sample, by chromatographic area, are the correct compound. The remaining fraction represents all detectable impurities combined. This threshold matters because research investigating telomerase activation pathways, pineal gland function, or circadian biology requires a compound that behaves predictably — trace impurities at even 2–3% can introduce confounding variables that distort in vitro results.
Short peptides like epithalon are, in some ways, easier to synthesize cleanly than 30+ amino acid chains, but they are not immune to side reactions during Fmoc SPPS coupling steps. Epithalon’s Asp-Gly dipeptide segment is particularly susceptible to aspartimide formation: under the basic conditions used for Fmoc removal, the free carboxyl of aspartic acid can cyclize with the adjacent glycine nitrogen, forming a succinimide ring that appears as a byproduct peak on the HPLC trace. Reputable synthesis protocols use piperazine or OxymaPure reagents to suppress this side reaction, and the final COA should show a clean output with no significant peaks in the aspartimide retention window.
The HPLC Certificate — and What It Doesn’t Tell You on Its Own
The standard COA from a quality supplier leads with reversed-phase HPLC data: a chromatogram showing a dominant single peak, the retention time in minutes, and an area% figure representing purity. What the HPLC trace confirms is relative homogeneity — it shows what fraction of the sample elutes as the correct compound under those mobile phase conditions.
What it does not confirm independently is identity. A high-purity HPLC trace showing 99.4% area could, in theory, reflect a contaminant with nearly identical retention time to the target compound. Mass spectrometry closes that gap. A MS reading confirming the expected molecular weight of epithalon (432.4 Da for the free acid form) rules out the possibility that a high-purity HPLC trace represents the wrong molecule.
Suppliers who provide both HPLC and MS data give researchers two-point confirmation. Third-party verification adds a further layer — Blank Peptides sends epithalon lots to Freedom Diagnostics and Horizon Analytical for independent analysis, which means the purity figure on the COA is not self-reported by the manufacturer.
Bacterial Endotoxin Testing and Why It’s Separate From Purity
A peptide can reach 99.9% HPLC purity and still be unsuitable for injection-route research if it carries a lipopolysaccharide burden from gram-negative bacterial contamination during synthesis or filling. Bacterial endotoxin testing — most commonly performed via the Limulus Amebocyte Lysate (LAL) assay — detects pyrogens at levels relevant to subcutaneous or intraperitoneal protocols. A compound should pass a defined threshold for bacterial endotoxin before being used in any in vivo study where an inflammatory response would confound results.
This test runs in parallel to, not instead of, HPLC purity work. Both results should appear in the documentation for any epithalon lot intended for in vivo or cell-culture research. When reviewing a COA, look for an endotoxin result expressed in EU/mg alongside the HPLC and MS figures — passing results for research-grade material are typically below 2 EU/mg.
Reading an Epithalon Certificate of Analysis
When reviewing a COA for epithalon, these are the items to check:
HPLC purity at or above 99%, accompanied by an actual chromatogram rather than just a reported number. A chromatogram lets you verify the peak shape and identify any impurity peaks the supplier might otherwise omit from a summary table.
Mass spectrometric identity confirmation matching the expected molecular weight — not just the compound name. For the free acid form, the expected MW is 432.4 Da; check that the observed ion series is consistent.
A lot number traceable to a specific synthesis batch. If your experiment yields unexpected results, you need to be able to identify whether a particular lot was involved.
A bacterial endotoxin result with a pass/fail and EU/mg value, not just a “pass” stamp.
The third-party laboratory name. In-house testing is not equivalent to independent third-party verification from an accredited facility.
For researchers running multi-compound protocols, the same documentation standard should apply across the board. Compounds like NAD+ and SS-31 are commonly used alongside epithalon in longevity and mitochondrial research contexts, and consistent sourcing and QC standards across all compounds in a research program makes cross-compound comparisons more valid.
FAQ
Does a lot-level COA guarantee that every vial in the batch meets the stated purity?
A lot-level COA represents the batch as a whole, not every individual vial. Reputable suppliers run HPLC on pooled or representative samples from the batch. In practice, lyophilization and vial-filling under controlled conditions do not typically introduce significant purity variability between vials — the risk points are in synthesis and processing, which happen before filling. Worth asking any supplier, however, whether testing is per-vial or per-batch, and how the sampling protocol is structured.
Why is the Asp-Gly sequence in epithalon particularly risky during synthesis?
Aspartimide formation is a well-documented side reaction specific to Asp-X sequences in Fmoc SPPS. The aspartic acid carboxyl groups are activated during synthesis and, under basic deprotection conditions, can cyclize with the adjacent residue to form a succinimide ring. This creates a byproduct that is close in mass and retention time to the correct peptide but biologically distinct. Checking the MS data for +18 Da or -18 Da satellite peaks — the signatures of aspartimide and its hydrolysis product — is one way to verify the issue was controlled.
Is HPLC-area purity the same thing as mass purity?
Not exactly. HPLC area% purity is based on UV absorbance at a set wavelength (typically 214 nm or 220 nm), which is proportional to peptide bond content. Different compounds absorb differently, so area% is an approximation of mass purity rather than a direct measurement. For a single compound like epithalon being compared to its own synthesis byproducts, the relationship is close enough for routine quality assessment, but it is worth understanding that the 99% figure represents chromatographic homogeneity, not a direct mass balance.
All products discussed are for laboratory research use only and are not for human or veterinary use.